STOK
$20.31
Stoke Therapeutics
($3.54)
(14.84%)
STOK
Earnings Whisper ®
N/A
4th Quarter December 2021
Consensus:  ($0.61)
Revenue:  $0.00 Mil
Monday
Feb 7
7:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when STOK reports earnings?
Beat
Meet
Miss

Where is STOK's stock price going from here?
Up
Flat
Down
Stock chart of STOK
Analysts
Summary of analysts' recommendations for STOK
Score
Grade
Pivots
Resistance
$28.96
$27.04
$23.68

$21.76

Support
$18.39
$16.47
$13.11
Tweet
Growth
Description
Stoke Therapeutics Inc. is a biopharmaceutical company. It develops antisense oligonucleotide medicines to treat genetic diseases. The company's product candidate consists of STK-001 which is to treat Dravet syndrome, a severe and progressive genetic epilepsy. Stoke Therapeutics Inc. is based in Bedford, Massachusetts.